Skip to content

Milestone Pharmaceuticals Inc.

MIST· NasdaqCore metricsCIK 1408443

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -4.08%
Market cap
$80.97M
124.5M shares
Filings
423
$963.00K
Q3 2026
—
-$25.80M
Q3 2026N/M FY25 yoy
-$25.05M
Q3 2026N/M FY25 yoy
-$64.08M
Q3 2026derivedN/M FY25 yoy
-$0.18
Q3 2026N/M FY25 yoy
$144.47M
Q3 2026+188.6% FY25 yoy
$80.97M
—
—
—
-60.94%
—

FY2025 figures · derived

Price

$0.650465.95%$1.2596past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$963.00KQ3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Pharmaceutical preparations

Milestone Pharmaceuticals Inc. is the 301st largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Milestone Pharmaceuticals Inc. · CIK 1408443 · Engraved from SEC EDGAR